nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ALB—Crohn's disease	0.478	1	CbGaD
Captopril—F2—portal vein—Crohn's disease	0.0346	0.184	CbGeAlD
Captopril—LTA4H—mouth—Crohn's disease	0.00982	0.0523	CbGeAlD
Captopril—Pulmonary eosinophilia—Mesalazine—Crohn's disease	0.00847	0.0475	CcSEcCtD
Captopril—MMP2—gall bladder—Crohn's disease	0.00784	0.0417	CbGeAlD
Captopril—REN—mouth—Crohn's disease	0.00758	0.0404	CbGeAlD
Captopril—MMP2—mouth—Crohn's disease	0.00697	0.0371	CbGeAlD
Captopril—MMP9—mouth—Crohn's disease	0.00606	0.0323	CbGeAlD
Captopril—F2—gall bladder—Crohn's disease	0.00595	0.0317	CbGeAlD
Captopril—Renal failure chronic—Mesalazine—Crohn's disease	0.00575	0.0322	CcSEcCtD
Captopril—Red blood cell sedimentation rate increased—Mesalazine—Crohn's disease	0.00575	0.0322	CcSEcCtD
Captopril—LTA4H—smooth muscle tissue—Crohn's disease	0.00551	0.0293	CbGeAlD
Captopril—LTA4H—mammalian vulva—Crohn's disease	0.00496	0.0264	CbGeAlD
Captopril—Hepatic necrosis—Mercaptopurine—Crohn's disease	0.00491	0.0275	CcSEcCtD
Captopril—Nephritis—Mesalazine—Crohn's disease	0.00453	0.0254	CcSEcCtD
Captopril—REN—epithelium—Crohn's disease	0.00441	0.0235	CbGeAlD
Captopril—LTA4H—lymphoid tissue—Crohn's disease	0.0044	0.0234	CbGeAlD
Captopril—LTA4H—digestive system—Crohn's disease	0.00435	0.0231	CbGeAlD
Captopril—REN—smooth muscle tissue—Crohn's disease	0.00425	0.0226	CbGeAlD
Captopril—MMP2—epithelium—Crohn's disease	0.00405	0.0216	CbGeAlD
Captopril—MMP2—smooth muscle tissue—Crohn's disease	0.00391	0.0208	CbGeAlD
Captopril—MMP2—skin of body—Crohn's disease	0.00386	0.0205	CbGeAlD
Captopril—ALB—gall bladder—Crohn's disease	0.0038	0.0202	CbGeAlD
Captopril—Cholestasis—Mercaptopurine—Crohn's disease	0.00376	0.021	CcSEcCtD
Captopril—MMP9—epithelium—Crohn's disease	0.00353	0.0188	CbGeAlD
Captopril—MMP2—mammalian vulva—Crohn's disease	0.00352	0.0187	CbGeAlD
Captopril—MMP9—smooth muscle tissue—Crohn's disease	0.0034	0.0181	CbGeAlD
Captopril—Liver injury—Mercaptopurine—Crohn's disease	0.00339	0.019	CcSEcCtD
Captopril—REN—digestive system—Crohn's disease	0.00336	0.0179	CbGeAlD
Captopril—MMP9—skin of body—Crohn's disease	0.00335	0.0179	CbGeAlD
Captopril—ACE—mouth—Crohn's disease	0.00323	0.0172	CbGeAlD
Captopril—Nephrotic syndrome—Mesalazine—Crohn's disease	0.0032	0.018	CcSEcCtD
Captopril—MMP2—lymphoid tissue—Crohn's disease	0.00312	0.0166	CbGeAlD
Captopril—MMP2—digestive system—Crohn's disease	0.00308	0.0164	CbGeAlD
Captopril—F2—epithelium—Crohn's disease	0.00308	0.0164	CbGeAlD
Captopril—Ulcer—Mercaptopurine—Crohn's disease	0.00302	0.0169	CcSEcCtD
Captopril—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00285	0.016	CcSEcCtD
Captopril—MMP9—lymphoid tissue—Crohn's disease	0.00272	0.0145	CbGeAlD
Captopril—Blood potassium increased—Prednisone—Crohn's disease	0.00271	0.0152	CcSEcCtD
Captopril—MMP9—digestive system—Crohn's disease	0.00268	0.0143	CbGeAlD
Captopril—Hepatic necrosis—Mesalazine—Crohn's disease	0.00266	0.0149	CcSEcCtD
Captopril—SLC15A1—epithelium—Crohn's disease	0.00262	0.014	CbGeAlD
Captopril—LTA4H—lymph node—Crohn's disease	0.00248	0.0132	CbGeAlD
Captopril—F2—lymphoid tissue—Crohn's disease	0.00237	0.0126	CbGeAlD
Captopril—F2—digestive system—Crohn's disease	0.00234	0.0125	CbGeAlD
Captopril—Nephritis interstitial—Mesalazine—Crohn's disease	0.00229	0.0129	CcSEcCtD
Captopril—SLC15A1—mammalian vulva—Crohn's disease	0.00227	0.0121	CbGeAlD
Captopril—Cholestasis—Azathioprine—Crohn's disease	0.00224	0.0125	CcSEcCtD
Captopril—Blister—Mesalazine—Crohn's disease	0.00215	0.012	CcSEcCtD
Captopril—Gastric irritation—Prednisone—Crohn's disease	0.00211	0.0118	CcSEcCtD
Captopril—Cholestasis—Mesalazine—Crohn's disease	0.00204	0.0114	CcSEcCtD
Captopril—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00202	0.0113	CcSEcCtD
Captopril—Liver injury—Azathioprine—Crohn's disease	0.00202	0.0113	CcSEcCtD
Captopril—SLC15A1—digestive system—Crohn's disease	0.00199	0.0106	CbGeAlD
Captopril—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00193	0.0108	CcSEcCtD
Captopril—ACE—epithelium—Crohn's disease	0.00188	0.01	CbGeAlD
Captopril—Liver injury—Mesalazine—Crohn's disease	0.00184	0.0103	CcSEcCtD
Captopril—ACE—smooth muscle tissue—Crohn's disease	0.00181	0.00964	CbGeAlD
Captopril—MMP2—Dexamethasone—Prednisone—Crohn's disease	0.00177	0.5	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisone—Crohn's disease	0.00177	0.5	CbGdCrCtD
Captopril—MMP2—lymph node—Crohn's disease	0.00176	0.00938	CbGeAlD
Captopril—Proteinuria—Mesalazine—Crohn's disease	0.00176	0.00987	CcSEcCtD
Captopril—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00176	0.00987	CcSEcCtD
Captopril—Pancreatitis—Mercaptopurine—Crohn's disease	0.00175	0.00983	CcSEcCtD
Captopril—Vasculitis—Azathioprine—Crohn's disease	0.00174	0.00976	CcSEcCtD
Captopril—Protein urine present—Mesalazine—Crohn's disease	0.00174	0.00974	CcSEcCtD
Captopril—Hepatocellular injury—Azathioprine—Crohn's disease	0.0017	0.00952	CcSEcCtD
Captopril—Pancytopenia—Mercaptopurine—Crohn's disease	0.0017	0.00952	CcSEcCtD
Captopril—ACE—mammalian vulva—Crohn's disease	0.00163	0.00868	CbGeAlD
Captopril—Epigastric discomfort—Prednisone—Crohn's disease	0.00156	0.00873	CcSEcCtD
Captopril—Stomatitis—Mercaptopurine—Crohn's disease	0.00155	0.00872	CcSEcCtD
Captopril—Hepatocellular injury—Mesalazine—Crohn's disease	0.00155	0.00868	CcSEcCtD
Captopril—MMP9—lymph node—Crohn's disease	0.00153	0.00816	CbGeAlD
Captopril—ACE—lymphoid tissue—Crohn's disease	0.00145	0.0077	CbGeAlD
Captopril—ACE—digestive system—Crohn's disease	0.00143	0.00761	CbGeAlD
Captopril—Dry eye—Mesalazine—Crohn's disease	0.00143	0.00801	CcSEcCtD
Captopril—Lymphadenopathy—Mesalazine—Crohn's disease	0.00132	0.00738	CcSEcCtD
Captopril—Photosensitivity—Mesalazine—Crohn's disease	0.00128	0.00717	CcSEcCtD
Captopril—Alopecia—Mercaptopurine—Crohn's disease	0.00127	0.00709	CcSEcCtD
Captopril—Peptic ulcer—Prednisone—Crohn's disease	0.00123	0.00687	CcSEcCtD
Captopril—Renal failure acute—Mesalazine—Crohn's disease	0.00122	0.00682	CcSEcCtD
Captopril—Dermatitis bullous—Mesalazine—Crohn's disease	0.00118	0.00659	CcSEcCtD
Captopril—Anaemia—Mercaptopurine—Crohn's disease	0.00115	0.00646	CcSEcCtD
Captopril—Arthralgia—Mercaptopurine—Crohn's disease	0.00106	0.00595	CcSEcCtD
Captopril—Pancreatitis—Azathioprine—Crohn's disease	0.00105	0.00586	CcSEcCtD
Captopril—Necrosis—Prednisone—Crohn's disease	0.00104	0.00585	CcSEcCtD
Captopril—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00103	0.00575	CcSEcCtD
Captopril—Pancytopenia—Azathioprine—Crohn's disease	0.00101	0.00567	CcSEcCtD
Captopril—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000996	0.00558	CcSEcCtD
Captopril—Anorexia—Mercaptopurine—Crohn's disease	0.00097	0.00544	CcSEcCtD
Captopril—Eosinophilia—Mesalazine—Crohn's disease	0.000961	0.00539	CcSEcCtD
Captopril—Bronchospasm—Mesalazine—Crohn's disease	0.000955	0.00535	CcSEcCtD
Captopril—Pancreatitis—Mesalazine—Crohn's disease	0.000952	0.00534	CcSEcCtD
Captopril—Angina pectoris—Mesalazine—Crohn's disease	0.000946	0.0053	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000942	0.00528	CcSEcCtD
Captopril—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000927	0.0052	CcSEcCtD
Captopril—Pancytopenia—Mesalazine—Crohn's disease	0.000922	0.00517	CcSEcCtD
Captopril—Neutropenia—Mesalazine—Crohn's disease	0.000908	0.00509	CcSEcCtD
Captopril—Pollakiuria—Mesalazine—Crohn's disease	0.000897	0.00503	CcSEcCtD
Captopril—Agranulocytosis—Azathioprine—Crohn's disease	0.000887	0.00497	CcSEcCtD
Captopril—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000886	0.00497	CcSEcCtD
Captopril—Decreased appetite—Mercaptopurine—Crohn's disease	0.000884	0.00496	CcSEcCtD
Captopril—Weight decreased—Mesalazine—Crohn's disease	0.000879	0.00492	CcSEcCtD
Captopril—Ulcer—Prednisone—Crohn's disease	0.000866	0.00485	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000858	0.00481	CcSEcCtD
Captopril—ALB—lymph node—Crohn's disease	0.000853	0.00454	CbGeAlD
Captopril—Renal failure—Mesalazine—Crohn's disease	0.000851	0.00477	CcSEcCtD
Captopril—Stomatitis—Mesalazine—Crohn's disease	0.000844	0.00473	CcSEcCtD
Captopril—Jaundice—Mesalazine—Crohn's disease	0.000844	0.00473	CcSEcCtD
Captopril—Vasculitis—Prednisone—Crohn's disease	0.000839	0.0047	CcSEcCtD
Captopril—ACE—lymph node—Crohn's disease	0.000817	0.00435	CbGeAlD
Captopril—Agranulocytosis—Mesalazine—Crohn's disease	0.000808	0.00453	CcSEcCtD
Captopril—Erythema multiforme—Azathioprine—Crohn's disease	0.000807	0.00452	CcSEcCtD
Captopril—Body temperature increased—Mercaptopurine—Crohn's disease	0.000804	0.00451	CcSEcCtD
Captopril—Rhinitis—Mesalazine—Crohn's disease	0.000779	0.00437	CcSEcCtD
Captopril—Hepatitis—Mesalazine—Crohn's disease	0.000777	0.00436	CcSEcCtD
Captopril—Pharyngitis—Mesalazine—Crohn's disease	0.000771	0.00432	CcSEcCtD
Captopril—Alopecia—Azathioprine—Crohn's disease	0.000754	0.00423	CcSEcCtD
Captopril—Erythema multiforme—Mesalazine—Crohn's disease	0.000735	0.00412	CcSEcCtD
Captopril—CYP2D6—digestive system—Crohn's disease	0.0007	0.00372	CbGeAlD
Captopril—Diarrhoea—Mercaptopurine—Crohn's disease	0.000696	0.0039	CcSEcCtD
Captopril—Ill-defined disorder—Azathioprine—Crohn's disease	0.000689	0.00386	CcSEcCtD
Captopril—Alopecia—Mesalazine—Crohn's disease	0.000687	0.00385	CcSEcCtD
Captopril—Anaemia—Azathioprine—Crohn's disease	0.000687	0.00385	CcSEcCtD
Captopril—Diabetes mellitus—Prednisone—Crohn's disease	0.000683	0.00383	CcSEcCtD
Captopril—Malaise—Azathioprine—Crohn's disease	0.00067	0.00375	CcSEcCtD
Captopril—Tension—Mesalazine—Crohn's disease	0.000664	0.00372	CcSEcCtD
Captopril—Dysgeusia—Mesalazine—Crohn's disease	0.000663	0.00371	CcSEcCtD
Captopril—ABCB1—epithelium—Crohn's disease	0.000662	0.00352	CbGeAlD
Captopril—Nervousness—Mesalazine—Crohn's disease	0.000657	0.00368	CcSEcCtD
Captopril—Vomiting—Mercaptopurine—Crohn's disease	0.000647	0.00363	CcSEcCtD
Captopril—Rash—Mercaptopurine—Crohn's disease	0.000642	0.0036	CcSEcCtD
Captopril—Dermatitis—Mercaptopurine—Crohn's disease	0.000641	0.00359	CcSEcCtD
Captopril—Vision blurred—Mesalazine—Crohn's disease	0.000638	0.00357	CcSEcCtD
Captopril—Arthralgia—Azathioprine—Crohn's disease	0.000632	0.00354	CcSEcCtD
Captopril—Myalgia—Azathioprine—Crohn's disease	0.000632	0.00354	CcSEcCtD
Captopril—Ill-defined disorder—Mesalazine—Crohn's disease	0.000628	0.00352	CcSEcCtD
Captopril—Anaemia—Mesalazine—Crohn's disease	0.000625	0.00351	CcSEcCtD
Captopril—Discomfort—Azathioprine—Crohn's disease	0.000625	0.0035	CcSEcCtD
Captopril—Angioedema—Mesalazine—Crohn's disease	0.000618	0.00347	CcSEcCtD
Captopril—Malaise—Mesalazine—Crohn's disease	0.00061	0.00342	CcSEcCtD
Captopril—Syncope—Mesalazine—Crohn's disease	0.000607	0.0034	CcSEcCtD
Captopril—Nausea—Mercaptopurine—Crohn's disease	0.000604	0.00339	CcSEcCtD
Captopril—Palpitations—Mesalazine—Crohn's disease	0.000598	0.00335	CcSEcCtD
Captopril—Loss of consciousness—Mesalazine—Crohn's disease	0.000595	0.00333	CcSEcCtD
Captopril—Thrombocytopenia—Azathioprine—Crohn's disease	0.000594	0.00333	CcSEcCtD
Captopril—Cough—Mesalazine—Crohn's disease	0.00059	0.00331	CcSEcCtD
Captopril—Chest pain—Mesalazine—Crohn's disease	0.000576	0.00323	CcSEcCtD
Captopril—Myalgia—Mesalazine—Crohn's disease	0.000576	0.00323	CcSEcCtD
Captopril—Arthralgia—Mesalazine—Crohn's disease	0.000576	0.00323	CcSEcCtD
Captopril—ABCB1—mammalian vulva—Crohn's disease	0.000574	0.00305	CbGeAlD
Captopril—Discomfort—Mesalazine—Crohn's disease	0.000569	0.00319	CcSEcCtD
Captopril—Hypotension—Azathioprine—Crohn's disease	0.000566	0.00318	CcSEcCtD
Captopril—Cardiac arrest—Prednisone—Crohn's disease	0.000565	0.00317	CcSEcCtD
Captopril—Dry mouth—Mesalazine—Crohn's disease	0.000563	0.00316	CcSEcCtD
Captopril—Confusional state—Mesalazine—Crohn's disease	0.000557	0.00312	CcSEcCtD
Captopril—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000552	0.0031	CcSEcCtD
Captopril—Anaphylactic shock—Mesalazine—Crohn's disease	0.000552	0.0031	CcSEcCtD
Captopril—Shock—Mesalazine—Crohn's disease	0.000543	0.00305	CcSEcCtD
Captopril—Thrombocytopenia—Mesalazine—Crohn's disease	0.000541	0.00303	CcSEcCtD
Captopril—Tachycardia—Mesalazine—Crohn's disease	0.000539	0.00302	CcSEcCtD
Captopril—Anorexia—Mesalazine—Crohn's disease	0.000526	0.00295	CcSEcCtD
Captopril—Muscular weakness—Prednisone—Crohn's disease	0.000524	0.00294	CcSEcCtD
Captopril—Hypotension—Mesalazine—Crohn's disease	0.000516	0.00289	CcSEcCtD
Captopril—ABCB1—lymphoid tissue—Crohn's disease	0.000509	0.00271	CbGeAlD
Captopril—Pancreatitis—Prednisone—Crohn's disease	0.000504	0.00282	CcSEcCtD
Captopril—ABCB1—digestive system—Crohn's disease	0.000503	0.00268	CbGeAlD
Captopril—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000503	0.00282	CcSEcCtD
Captopril—Feeling abnormal—Azathioprine—Crohn's disease	0.0005	0.0028	CcSEcCtD
Captopril—Insomnia—Mesalazine—Crohn's disease	0.000499	0.0028	CcSEcCtD
Captopril—Paraesthesia—Mesalazine—Crohn's disease	0.000496	0.00278	CcSEcCtD
Captopril—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000496	0.00278	CcSEcCtD
Captopril—Dyspnoea—Mesalazine—Crohn's disease	0.000492	0.00276	CcSEcCtD
Captopril—Somnolence—Mesalazine—Crohn's disease	0.000491	0.00275	CcSEcCtD
Captopril—Dyspepsia—Mesalazine—Crohn's disease	0.000486	0.00272	CcSEcCtD
Captopril—Neutropenia—Prednisone—Crohn's disease	0.00048	0.00269	CcSEcCtD
Captopril—Decreased appetite—Mesalazine—Crohn's disease	0.00048	0.00269	CcSEcCtD
Captopril—Abdominal pain—Azathioprine—Crohn's disease	0.000479	0.00269	CcSEcCtD
Captopril—Body temperature increased—Azathioprine—Crohn's disease	0.000479	0.00269	CcSEcCtD
Captopril—Fatigue—Mesalazine—Crohn's disease	0.000476	0.00267	CcSEcCtD
Captopril—Erectile dysfunction—Prednisone—Crohn's disease	0.000473	0.00265	CcSEcCtD
Captopril—Constipation—Mesalazine—Crohn's disease	0.000472	0.00265	CcSEcCtD
Captopril—Weight decreased—Prednisone—Crohn's disease	0.000465	0.00261	CcSEcCtD
Captopril—Feeling abnormal—Mesalazine—Crohn's disease	0.000455	0.00255	CcSEcCtD
Captopril—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000452	0.00253	CcSEcCtD
Captopril—Abdominal pain—Mesalazine—Crohn's disease	0.000437	0.00245	CcSEcCtD
Captopril—Body temperature increased—Mesalazine—Crohn's disease	0.000437	0.00245	CcSEcCtD
Captopril—Diarrhoea—Azathioprine—Crohn's disease	0.000415	0.00233	CcSEcCtD
Captopril—Hallucination—Prednisone—Crohn's disease	0.000409	0.00229	CcSEcCtD
Captopril—Dizziness—Azathioprine—Crohn's disease	0.000401	0.00225	CcSEcCtD
Captopril—Asthenia—Mesalazine—Crohn's disease	0.000396	0.00222	CcSEcCtD
Captopril—Pruritus—Mesalazine—Crohn's disease	0.000391	0.00219	CcSEcCtD
Captopril—Vomiting—Azathioprine—Crohn's disease	0.000385	0.00216	CcSEcCtD
Captopril—Rash—Azathioprine—Crohn's disease	0.000382	0.00214	CcSEcCtD
Captopril—Dermatitis—Azathioprine—Crohn's disease	0.000382	0.00214	CcSEcCtD
Captopril—Flushing—Prednisone—Crohn's disease	0.000382	0.00214	CcSEcCtD
Captopril—Headache—Azathioprine—Crohn's disease	0.00038	0.00213	CcSEcCtD
Captopril—Diarrhoea—Mesalazine—Crohn's disease	0.000378	0.00212	CcSEcCtD
Captopril—Dizziness—Mesalazine—Crohn's disease	0.000365	0.00205	CcSEcCtD
Captopril—Alopecia—Prednisone—Crohn's disease	0.000363	0.00204	CcSEcCtD
Captopril—Nausea—Azathioprine—Crohn's disease	0.00036	0.00202	CcSEcCtD
Captopril—Vomiting—Mesalazine—Crohn's disease	0.000351	0.00197	CcSEcCtD
Captopril—Rash—Mesalazine—Crohn's disease	0.000348	0.00195	CcSEcCtD
Captopril—Dermatitis—Mesalazine—Crohn's disease	0.000348	0.00195	CcSEcCtD
Captopril—Headache—Mesalazine—Crohn's disease	0.000346	0.00194	CcSEcCtD
Captopril—Vision blurred—Prednisone—Crohn's disease	0.000337	0.00189	CcSEcCtD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000336	0.0022	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000335	0.0022	CbGpPWpGaD
Captopril—Ill-defined disorder—Prednisone—Crohn's disease	0.000332	0.00186	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Crohn's disease	0.000331	0.00217	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CD4—Crohn's disease	0.000331	0.00217	CbGpPWpGaD
Captopril—Anaemia—Prednisone—Crohn's disease	0.000331	0.00185	CcSEcCtD
Captopril—Nausea—Mesalazine—Crohn's disease	0.000328	0.00184	CcSEcCtD
Captopril—Angioedema—Prednisone—Crohn's disease	0.000327	0.00183	CcSEcCtD
Captopril—Malaise—Prednisone—Crohn's disease	0.000323	0.00181	CcSEcCtD
Captopril—Syncope—Prednisone—Crohn's disease	0.000321	0.0018	CcSEcCtD
Captopril—F2—Folate Metabolism—IFNG—Crohn's disease	0.000321	0.0021	CbGpPWpGaD
Captopril—Loss of consciousness—Prednisone—Crohn's disease	0.000315	0.00176	CcSEcCtD
Captopril—MMP9—TWEAK Signaling Pathway—IL6—Crohn's disease	0.000312	0.00204	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—STAT3—Crohn's disease	0.000311	0.00204	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR9—Crohn's disease	0.000307	0.00201	CbGpPWpGaD
Captopril—Myalgia—Prednisone—Crohn's disease	0.000305	0.00171	CcSEcCtD
Captopril—Arthralgia—Prednisone—Crohn's disease	0.000305	0.00171	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—ITGA4—Crohn's disease	0.000304	0.00199	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000301	0.00197	CbGpPWpGaD
Captopril—Discomfort—Prednisone—Crohn's disease	0.000301	0.00169	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—Crohn's disease	0.000292	0.00164	CcSEcCtD
Captopril—F2—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000292	0.00191	CbGpPWpGaD
Captopril—ABCB1—lymph node—Crohn's disease	0.000287	0.00153	CbGeAlD
Captopril—Shock—Prednisone—Crohn's disease	0.000287	0.00161	CcSEcCtD
Captopril—F2—Folate Metabolism—IL1B—Crohn's disease	0.000286	0.00188	CbGpPWpGaD
Captopril—Tachycardia—Prednisone—Crohn's disease	0.000285	0.0016	CcSEcCtD
Captopril—F2—GPCR ligand binding—GPR65—Crohn's disease	0.000285	0.00187	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000282	0.00185	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—ALB—Crohn's disease	0.000279	0.00183	CbGpPWpGaD
Captopril—Anorexia—Prednisone—Crohn's disease	0.000278	0.00156	CcSEcCtD
Captopril—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	0.000275	0.0018	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—ICAM1—Crohn's disease	0.000275	0.0018	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000274	0.00179	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000274	0.00179	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000267	0.00175	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000266	0.00149	CcSEcCtD
Captopril—Insomnia—Prednisone—Crohn's disease	0.000264	0.00148	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000264	0.00173	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000263	0.00173	CbGpPWpGaD
Captopril—Paraesthesia—Prednisone—Crohn's disease	0.000262	0.00147	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IFNG—Crohn's disease	0.000261	0.00171	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000261	0.00171	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—Crohn's disease	0.000259	0.0017	CbGpPWpGaD
Captopril—Dyspepsia—Prednisone—Crohn's disease	0.000257	0.00144	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—STAT3—Crohn's disease	0.000256	0.00168	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.000255	0.00167	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—TNF—Crohn's disease	0.000255	0.00167	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000255	0.00167	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000255	0.00167	CbGpPWpGaD
Captopril—Decreased appetite—Prednisone—Crohn's disease	0.000254	0.00142	CcSEcCtD
Captopril—Fatigue—Prednisone—Crohn's disease	0.000252	0.00141	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—PTGS2—Crohn's disease	0.00025	0.00164	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—MLN—Crohn's disease	0.00025	0.00164	CbGpPWpGaD
Captopril—Constipation—Prednisone—Crohn's disease	0.00025	0.0014	CcSEcCtD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000249	0.00163	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.000244	0.0016	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CXCL8—Crohn's disease	0.000243	0.00159	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—TYK2—Crohn's disease	0.000242	0.00159	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000242	0.00158	CbGpPWpGaD
Captopril—Feeling abnormal—Prednisone—Crohn's disease	0.000241	0.00135	CcSEcCtD
Captopril—F2—Signaling by GPCR—ACKR2—Crohn's disease	0.000239	0.00157	CbGpPWpGaD
Captopril—Gastrointestinal pain—Prednisone—Crohn's disease	0.000239	0.00134	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000235	0.00154	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL1B—Crohn's disease	0.000233	0.00153	CbGpPWpGaD
Captopril—Body temperature increased—Prednisone—Crohn's disease	0.000231	0.00129	CcSEcCtD
Captopril—Abdominal pain—Prednisone—Crohn's disease	0.000231	0.00129	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—JAK2—Crohn's disease	0.000231	0.00151	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000227	0.00149	CbGpPWpGaD
Captopril—F2—Hemostasis—F5—Crohn's disease	0.000227	0.00149	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MLN—Crohn's disease	0.000227	0.00149	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000225	0.00147	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000224	0.00147	CbGpPWpGaD
Captopril—Asthenia—Prednisone—Crohn's disease	0.00021	0.00117	CcSEcCtD
Captopril—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000208	0.00136	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000208	0.00136	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TNF—Crohn's disease	0.000208	0.00136	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—SMAD3—Crohn's disease	0.000207	0.00136	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL6—Crohn's disease	0.000207	0.00136	CbGpPWpGaD
Captopril—Pruritus—Prednisone—Crohn's disease	0.000207	0.00116	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—IL6—Crohn's disease	0.000206	0.00135	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000206	0.00135	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000203	0.00133	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000203	0.00133	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR6—Crohn's disease	0.000203	0.00133	CbGpPWpGaD
Captopril—Diarrhoea—Prednisone—Crohn's disease	0.0002	0.00112	CcSEcCtD
Captopril—Dizziness—Prednisone—Crohn's disease	0.000193	0.00108	CcSEcCtD
Captopril—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000193	0.00126	CbGpPWpGaD
Captopril—MMP2—Axon guidance—TYK2—Crohn's disease	0.00019	0.00124	CbGpPWpGaD
Captopril—Vomiting—Prednisone—Crohn's disease	0.000186	0.00104	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.000185	0.00121	CbGpPWpGaD
Captopril—Rash—Prednisone—Crohn's disease	0.000184	0.00103	CcSEcCtD
Captopril—Dermatitis—Prednisone—Crohn's disease	0.000184	0.00103	CcSEcCtD
Captopril—MMP9—Signaling Pathways—ACKR2—Crohn's disease	0.000183	0.0012	CbGpPWpGaD
Captopril—Headache—Prednisone—Crohn's disease	0.000183	0.00103	CcSEcCtD
Captopril—REN—Metabolism of proteins—CXCL8—Crohn's disease	0.000183	0.0012	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000183	0.0012	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—CRP—Crohn's disease	0.000182	0.00119	CbGpPWpGaD
Captopril—MMP2—Axon guidance—JAK2—Crohn's disease	0.000181	0.00119	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—ICAM1—Crohn's disease	0.00018	0.00118	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—PTGER4—Crohn's disease	0.000179	0.00117	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000175	0.00115	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MLN—Crohn's disease	0.000174	0.00114	CbGpPWpGaD
Captopril—Nausea—Prednisone—Crohn's disease	0.000174	0.000973	CcSEcCtD
Captopril—F2—GPCR downstream signaling—CCR9—Crohn's disease	0.000173	0.00114	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000172	0.00113	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000171	0.00112	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—STAT3—Crohn's disease	0.000169	0.00111	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TNF—Crohn's disease	0.000169	0.00111	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL6—Crohn's disease	0.000168	0.0011	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—ICAM1—Crohn's disease	0.000167	0.0011	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—TNF—Crohn's disease	0.000165	0.00108	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000164	0.00108	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GPR65—Crohn's disease	0.000161	0.00106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TAGAP—Crohn's disease	0.000159	0.00104	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR9—Crohn's disease	0.000157	0.00103	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.000157	0.00103	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000147	0.00096	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000146	0.00096	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GPR65—Crohn's disease	0.000146	0.000958	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	0.000145	0.000948	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000143	0.000938	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ACKR2—Crohn's disease	0.000141	0.000927	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.00014	0.000915	CbGpPWpGaD
Captopril—F2—Hemostasis—ITGA4—Crohn's disease	0.00014	0.000915	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RSPO3—Crohn's disease	0.000139	0.00091	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—Crohn's disease	0.000136	0.000894	CbGpPWpGaD
Captopril—F2—Hemostasis—IL3—Crohn's disease	0.000136	0.000892	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SMAD3—Crohn's disease	0.000136	0.000891	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TYK2—Crohn's disease	0.000135	0.000886	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—Crohn's disease	0.000134	0.000879	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MLN—Crohn's disease	0.000134	0.000879	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000134	0.000877	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000133	0.000873	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—Crohn's disease	0.000133	0.000873	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000133	0.000872	CbGpPWpGaD
Captopril—F2—Hemostasis—RASGRP1—Crohn's disease	0.000132	0.000863	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SEL1L—Crohn's disease	0.000132	0.000862	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000131	0.000856	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000129	0.000848	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—JAK2—Crohn's disease	0.000129	0.000846	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000128	0.00084	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IFNG—Crohn's disease	0.000127	0.000835	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000127	0.000833	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000127	0.000829	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.000124	0.000815	CbGpPWpGaD
Captopril—MMP9—Axon guidance—TYK2—Crohn's disease	0.000124	0.000815	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TAGAP—Crohn's disease	0.000123	0.000804	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000121	0.000792	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR9—Crohn's disease	0.00012	0.000789	CbGpPWpGaD
Captopril—MMP9—Axon guidance—JAK2—Crohn's disease	0.000119	0.000777	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—Crohn's disease	0.000118	0.000775	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—Crohn's disease	0.000117	0.000769	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR6—Crohn's disease	0.000115	0.000752	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—Crohn's disease	0.000114	0.000745	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GPR65—Crohn's disease	0.000112	0.000733	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000111	0.000728	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RSPO3—Crohn's disease	0.000107	0.000702	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000106	0.000692	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000106	0.000692	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000105	0.000687	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR6—Crohn's disease	0.000104	0.000683	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000103	0.000676	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SEL1L—Crohn's disease	0.000102	0.000666	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.000101	0.000664	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	0.000101	0.000664	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000101	0.000663	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000101	0.000662	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	9.7e-05	0.000636	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—Crohn's disease	9.67e-05	0.000633	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2RA—Crohn's disease	9.54e-05	0.000625	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—STAT3—Crohn's disease	9.47e-05	0.000621	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR9—Crohn's disease	9.29e-05	0.000609	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—Crohn's disease	9.27e-05	0.000608	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.26e-05	0.000607	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.26e-05	0.000607	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTGER4—Crohn's disease	9.17e-05	0.000601	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—Crohn's disease	9.09e-05	0.000596	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	9.03e-05	0.000592	CbGpPWpGaD
Captopril—ALB—Hemostasis—F5—Crohn's disease	9.01e-05	0.000591	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	8.99e-05	0.000589	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.97e-05	0.000588	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TYK2—Crohn's disease	8.87e-05	0.000581	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.65e-05	0.000567	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GPR65—Crohn's disease	8.64e-05	0.000566	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—Crohn's disease	8.62e-05	0.000565	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL3—Crohn's disease	8.6e-05	0.000564	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.59e-05	0.000563	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—JAK2—Crohn's disease	8.46e-05	0.000555	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—RASGRP1—Crohn's disease	8.32e-05	0.000545	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—Crohn's disease	8.24e-05	0.00054	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—Crohn's disease	8.2e-05	0.000537	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	8.18e-05	0.000536	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—Crohn's disease	8.17e-05	0.000536	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.1e-05	0.000531	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR6—Crohn's disease	7.97e-05	0.000522	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL3—Crohn's disease	7.81e-05	0.000512	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RASGRP1—Crohn's disease	7.56e-05	0.000495	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.44e-05	0.000488	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	7.34e-05	0.000481	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RBX1—Crohn's disease	7.21e-05	0.000473	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTGER4—Crohn's disease	7.02e-05	0.00046	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—Crohn's disease	6.9e-05	0.000452	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—Crohn's disease	6.65e-05	0.000436	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—Crohn's disease	6.62e-05	0.000434	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.58e-05	0.000431	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	6.55e-05	0.000429	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—Crohn's disease	6.54e-05	0.000429	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.52e-05	0.000427	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.52e-05	0.000427	CbGpPWpGaD
Captopril—F2—Hemostasis—JAK2—Crohn's disease	6.41e-05	0.00042	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—UBE2D1—Crohn's disease	6.32e-05	0.000414	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—Crohn's disease	6.26e-05	0.00041	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—Crohn's disease	6.21e-05	0.000407	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR6—Crohn's disease	6.16e-05	0.000403	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.14e-05	0.000402	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RIPK2—Crohn's disease	6.13e-05	0.000402	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—Crohn's disease	6.08e-05	0.000399	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2RA—Crohn's disease	6.03e-05	0.000395	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL3—Crohn's disease	5.98e-05	0.000392	CbGpPWpGaD
Captopril—ALB—Metabolism—PLA2G4F—Crohn's disease	5.82e-05	0.000381	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RASGRP1—Crohn's disease	5.78e-05	0.000379	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.76e-05	0.000378	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RBX1—Crohn's disease	5.57e-05	0.000365	CbGpPWpGaD
Captopril—ALB—Hemostasis—ITGA4—Crohn's disease	5.54e-05	0.000363	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2RA—Crohn's disease	5.47e-05	0.000359	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTGER4—Crohn's disease	5.42e-05	0.000355	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL3—Crohn's disease	5.4e-05	0.000354	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—Crohn's disease	5.38e-05	0.000352	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	5.29e-05	0.000346	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SOCS1—Crohn's disease	5.24e-05	0.000343	CbGpPWpGaD
Captopril—ALB—Hemostasis—RASGRP1—Crohn's disease	5.23e-05	0.000342	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.1e-05	0.000334	CbGpPWpGaD
Captopril—ALB—Metabolism—MTMR3—Crohn's disease	4.95e-05	0.000324	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.93e-05	0.000323	CbGpPWpGaD
Captopril—F2—Signaling Pathways—UBE2D1—Crohn's disease	4.88e-05	0.00032	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	4.8e-05	0.000315	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RIPK2—Crohn's disease	4.73e-05	0.00031	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL3—Crohn's disease	4.62e-05	0.000303	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—Crohn's disease	4.6e-05	0.000302	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.57e-05	0.0003	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.56e-05	0.000299	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD3—Crohn's disease	4.52e-05	0.000296	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RASGRP1—Crohn's disease	4.46e-05	0.000293	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—Crohn's disease	4.34e-05	0.000284	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTMR3—Crohn's disease	4.33e-05	0.000284	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2RA—Crohn's disease	4.19e-05	0.000274	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTMR3—Crohn's disease	4.08e-05	0.000268	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—JAK2—Crohn's disease	4.05e-05	0.000266	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SOCS1—Crohn's disease	4.04e-05	0.000265	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TYK2—Crohn's disease	3.86e-05	0.000253	CbGpPWpGaD
Captopril—ALB—Metabolism—FADS1—Crohn's disease	3.85e-05	0.000253	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2RA—Crohn's disease	3.78e-05	0.000248	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—Crohn's disease	3.7e-05	0.000242	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—JAK2—Crohn's disease	3.68e-05	0.000241	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX4—Crohn's disease	3.61e-05	0.000237	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD3—Crohn's disease	3.49e-05	0.000229	CbGpPWpGaD
Captopril—ALB—Metabolism—GCKR—Crohn's disease	3.49e-05	0.000228	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FADS1—Crohn's disease	3.38e-05	0.000221	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—Crohn's disease	3.36e-05	0.00022	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2RA—Crohn's disease	3.23e-05	0.000212	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FADS1—Crohn's disease	3.18e-05	0.000209	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX4—Crohn's disease	3.16e-05	0.000207	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.09e-05	0.000202	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCKR—Crohn's disease	3.05e-05	0.0002	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX4—Crohn's disease	2.98e-05	0.000195	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TYK2—Crohn's disease	2.95e-05	0.000193	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCKR—Crohn's disease	2.88e-05	0.000189	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JAK2—Crohn's disease	2.81e-05	0.000184	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—Crohn's disease	2.57e-05	0.000168	CbGpPWpGaD
Captopril—ALB—Hemostasis—JAK2—Crohn's disease	2.54e-05	0.000167	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TYK2—Crohn's disease	2.28e-05	0.000149	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.18e-05	0.000143	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAK2—Crohn's disease	2.17e-05	0.000142	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.08e-05	0.000136	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—Crohn's disease	2.07e-05	0.000135	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—Crohn's disease	1.98e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—Crohn's disease	1.89e-05	0.000124	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—Crohn's disease	1.6e-05	0.000105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—Crohn's disease	1.44e-05	9.46e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—Crohn's disease	1.11e-05	7.3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—Crohn's disease	9.72e-06	6.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—Crohn's disease	9.71e-06	6.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—Crohn's disease	9.16e-06	6e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—Crohn's disease	8.5e-06	5.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—Crohn's disease	8.01e-06	5.25e-05	CbGpPWpGaD
